A senior surgeon has demanded a corporate homicide inquiry into how patients were treated at NHS Grampian, saying he spent more than a decade warning that people were dying after unnecessary bleeding. The complaint, reported by the BBC, is the latest sign that internal whistleblowing is not always enough to force change in the health service. It also raises fresh questions about how NHS boards respond when early warnings are not acted on quickly enough.
What the surgeon is alleging
Dr Mohammed Habib, a consultant surgeon, has asked for a corporate homicide probe into NHS Grampian, the public health board covering parts of the north-east of Scotland. He said he had been raising concerns about the board for a decade, including with government ministers and police. The complaint centres on claims that patients were unnecessarily bled to death during their care.
Dr Habib’s intervention reframes a long-running internal dispute as a matter of criminal accountability. For ten years, he said, his warnings about practice were repeatedly raised but not acted on. The implication is that the failures were known, documented and ignored, and that the people responsible should face scrutiny through the criminal courts rather than internal reviews alone.
Corporate homicide law is intended to apply where an organisation’s gross negligence causes death. Asking for such a probe is therefore a serious step: it is a claim that the standard of care fell so far that it became a matter of criminal responsibility, not merely professional error.
Why it matters
The case matters less for what has been proved and more for what it exposes about how the health service handles dangerous practice. When a senior surgeon feels he must appeal to ministers and police before his warnings are treated as a formal matter, it suggests the internal systems have broken down. Corporate homicide law is designed to deter the gravest organisation failures, and asking for it is a signal that the surgeon believes the board’s conduct crossed a legal line.
For patients and staff, the story is a reminder of how easily concerns can be lost in administrative process. NHS boards carry a duty to investigate clinical concerns promptly and transparently, and the test of whether that duty was met will be judged by how the authorities respond to the request for a corporate homicide probe. Any such probe would be scrutinised by clinicians, patient groups and the regulator. If it were to proceed, it would set a precedent for how the NHS responds when a senior surgeon believes the board has failed to act on repeated warnings.
ADVERTISEMENT
What happens next
Any corporate homicide inquiry would sit separately from any review already under way at NHS Grampian. Dr Habib’s request is understood to be with relevant authorities, who will decide how to respond. The direction of the inquiry, if one is opened, will shape how the board responds to every remaining concern from the decade in question.
Clinicians and patient-safety groups will now watch closely to see whether the complaint prompts wider scrutiny of how serious clinical concerns are escalated within the Scottish health service. If the request is taken up, it would mark a rare and significant escalation in the handling of a long-running grievance.



























We do not allow links of any sort in comments. No SPAM whatsoever. On topic comments only.